Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2371 of 6351
-
One shot to stop clots? new drug tested in knee surgery patients
Prevention OngoingThis study was to compare the study drug KN060 to enoxaparin, for the prevention of blood clotting and safety in patients undergoing total knee arthroplasty (TKA).
Phase 2 • Sponsor: Suzhou Alphamab Co., Ltd. • Aim: Prevention
Last updated Jun 26, 2026 18:15 UTC
-
New depression pill shows promise in Late-Stage trial
Symptom relief CompletedThis is a randomized, double-blind, placebo-controlled, multicenter study to evaluate the effects of NMRA-335140 (formerly BTRX-335140) on symptoms of depression in participants with Major Depressive Disorder (MDD). The study design consists of a Screening Period (up to 28 days),…
Phase 3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Massive global study tracks Durvalumab's Real-World impact on liver cancers
Knowledge-focused Recruiting nowGiven the number of anticipated durvalumab-based treatment launches in the hepatobiliary cancer space over the next 3 years, there is a need to capture contemporary real-world data across these indications. LIVER-R is a multi-country, multi-center, observational study of patients…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can a higher dose of cabozantinib outsmart advanced kidney cancer?
Disease control Recruiting nowThe goal of this clinical trial is to learn about the effects of a higher dose of ncabozantinib in patients with advanced renal cell carcinoma who have progressed on or after receiving cabozantinib treatment.
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can heating milk and egg make them safe for kids with EoE?
Disease control Recruiting nowThe objective of the study is to study whether the introduction of heated food products (more specifically heated hen's egg and/or cow's milk) in children with EoE would be possible without re-occurrence of the eosinophilic inflammation, while the intake of less heated products m…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a monthly ring replace the pill? new study tests Hormone-Free contraceptive
Disease control Recruiting nowThis will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.
Sponsor: Daré Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Ancient herb meets modern painkiller in battle against chronic prostatitis pain
Symptom relief CompletedClinical trial title:Efficacy and safety of Ningmitai capsule alone or combined with celecoxib in the treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A prospective, randomized, double-blind, multicenter clinical study Principal investigator:Zhou Huiliang …
Phase 4 • Sponsor: Xintian Pharmaceutical • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat ovarian and endometrial cancers
Disease control Recruiting nowThis phase Ib trial tests the safety, side effects, and best dose of M1774 when given with ZEN-3694 in treating patients with ovarian and endometrial cancer that has come back (recurrent). M1774 and ZEN-3694 may stop the growth of tumor cells by blocking some of the enzymes neede…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Texts and EHR nudges aim to close the breast cancer screening gap
Prevention CompletedIn this study, personalized nudges to clinicians and patients will be evaluated to help increase breast cancer screening rates in accordance with USPSTF guidelines among women with a primary care visit, with a particular emphasis on those at high risk for non-completion of cancer…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
Nerve block may ease headaches after brain bleed, reduce opioid use
Symptom relief Recruiting nowBLOCK-SAH is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial with a sequential parallel comparison design (SPCD) of bilateral pterygopalatine fossa (PPF) injections with 20mg ropivacaine + 4mg dexamethasone (active, PPF-block) compared to sa…
Phase 2 • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Bronchoscopy boost for ventilator pneumonia?
Disease control CompletedThis randomized controlled trial evaluated the clinical effect of fiberoptic bronchoscopy in the management of adult patients with severe ventilator-associated pneumonia (VAP). A total of 100 patients admitted to the Critical Care Department at Benha University Hospitals were enr…
Sponsor: Benha University • Aim: Disease control
Last updated Jun 26, 2026 13:04 UTC
-
New combo treatments for alopecia areata: microneedling plus lactic acid, vitamin d, or steroid
Disease control Recruiting nowAlopecia areata (AA) is an immunologically mediated disease characterized by non-scarring hair loss (Madni and Shapiro, 2000). AA is presented by rapid and complete hair loss in one or more round or oval patches, usually on the scalp, beard area, eyebrows, eyelashes, and less com…
Sponsor: Zagazig University • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New app could bring heart rehab home for valve patients
Disease control Recruiting nowThe vast majority of cardiac rehabilitation eligible individuals do not participate in center based cardiac rehabilitation (CBCR). While steps to encourage participation in CBCR are important, many individuals will still not participate for a variety of reasons. This randomized c…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Heart scan could save prostate cancer patients from hidden artery disease
Disease control Recruiting nowThis is a randomized pilot study of Coronary CT Angiography (CCTA) for coronary atherosclerosis vs. Usual Care in patients with prostate cancer who are either planning to begin, or are currently taking androgen deprivation therapy (ADT) .
Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Timing is everything: late scans may spot bladder cancer spread better
Diagnosis Recruiting nowThe goal of this study is to demonstrate a significant gain in sensitivity versus surgical curage (extended pelvic) for initial lymph node staging of late FDG-PET images (2.5 hours) versus standard images (1 hour), analyzed by side (right iliac/left iliac areas in Patients with m…
Sponsor: Hopital Foch • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
New heart stent study aims to improve artery treatment
Disease control Recruiting nowThe objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New pill shows promise for Tough-to-Treat blood pressure in kidney patients
Disease control CompletedThis is a randomized, double-blind (DB), placebo controlled, crossover study with a two-period, two-sequence (2x2) design evaluating the efficacy and safety of 25 mg QD lorundrostat (an aldosterone synthase inhibitor \[ASI\]) in addition to a SGLT2i for the treatment of hypertens…
Phase 2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New tool could help stop malaria spread by reading Parasite's mind
Knowledge-focused CompletedUnderstanding the sexual conversion of the malaria parasite is essential to interrupt malaria transmission. A new tool is developed that, based on expression analysis of sexual stage biomarkers, will estimate sexual conversion rates in natural infections.
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New Non-Opioid drug VX-548 tested for chronic leg nerve pain
Symptom relief CompletedThe purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.
Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Real-World dupilumab study aims to ease chronic itch
Disease control OngoingThis study is a prospective, multinational, observational investigation designed to elucidate the real-world effectiveness and treatment patterns of dupilumab therapy in adult patients diagnosed with prurigo nodularis (PN). The primary objective of this study is to comprehensive…
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 18:00 UTC